vs
Cardio Diagnostics Holdings, Inc.（CDIO）与IMMUCELL CORP（ICCC）财务数据对比。点击上方公司名可切换其他公司
IMMUCELL CORP的季度营收约是Cardio Diagnostics Holdings, Inc.的1548.8倍（$5.5M vs $3.6K）。IMMUCELL CORP同比增速更快（-8.4% vs -21.2%）。IMMUCELL CORP自由现金流更多（$-1.8M vs $-5.9M）。过去两年IMMUCELL CORP的营收复合增速更高（3.9% vs -52.8%）
Cardio Diagnostics Holdings, Inc.是一家专注于精准心血管医疗的企业，开发并商业化整合遗传与表观遗传技术的诊断检测产品，可早期识别冠心病、心力衰竭等心血管疾病，主要服务美国市场的医疗机构、临床实验室与患者。
ImmuCell Corp是一家总部位于美国的动物健康生物技术企业，主要研发、生产和销售以奶牛为主的家畜相关保健与治疗产品，核心产品包括乳腺炎等常见牛类疾病的防治方案，主要服务北美地区的畜牧养殖户和兽医机构。
CDIO vs ICCC — 直观对比
营收规模更大
ICCC
是对方的1548.8倍
$3.6K
营收增速更快
ICCC
高出12.8%
-21.2%
自由现金流更多
ICCC
多$4.1M
$-5.9M
两年增速更快
ICCC
近两年复合增速
-52.8%
损益表 — Q4 2025 vs Q3 2025
| 指标 | | |
|---|---|---|
| 营收 | $3.6K | $5.5M |
| 净利润 | — | $-139.7K |
| 毛利率 | — | 42.9% |
| 营业利润率 | — | 0.4% |
| 净利率 | — | -2.5% |
| 营收同比 | -21.2% | -8.4% |
| 净利润同比 | 3.6% | 80.1% |
| 每股收益（稀释后） | — | $-0.02 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CDIOICCC
| Q4 25 | $3.6K | — | ||
| Q3 25 | $2.9K | $5.5M | ||
| Q2 25 | $7.5K | $6.4M | ||
| Q1 25 | $940 | $8.1M | ||
| Q4 24 | $4.5K | $7.8M | ||
| Q3 24 | $6.6K | $6.0M | ||
| Q2 24 | $7.9K | $5.5M | ||
| Q1 24 | $15.9K | $7.3M |
净利润CDIOICCC
| Q4 25 | — | — | ||
| Q3 25 | $-1.7M | $-139.7K | ||
| Q2 25 | $-1.7M | $501.9K | ||
| Q1 25 | $-1.6M | $1.4M | ||
| Q4 24 | — | — | ||
| Q3 24 | $-1.4M | $-701.7K | ||
| Q2 24 | $-1.3M | $-1.5M | ||
| Q1 24 | $-4.2M | $-437.9K |
毛利率CDIOICCC
| Q4 25 | — | — | ||
| Q3 25 | — | 42.9% | ||
| Q2 25 | — | 43.7% | ||
| Q1 25 | — | 41.6% | ||
| Q4 24 | — | 36.5% | ||
| Q3 24 | — | 26.3% | ||
| Q2 24 | — | 22.5% | ||
| Q1 24 | — | 31.6% |
营业利润率CDIOICCC
| Q4 25 | — | — | ||
| Q3 25 | -59950.9% | 0.4% | ||
| Q2 25 | -22457.5% | 8.8% | ||
| Q1 25 | -173463.8% | 13.9% | ||
| Q4 24 | — | 8.0% | ||
| Q3 24 | -21412.9% | -9.6% | ||
| Q2 24 | -16295.6% | -25.3% | ||
| Q1 24 | -26105.3% | -4.1% |
净利率CDIOICCC
| Q4 25 | — | — | ||
| Q3 25 | -60053.8% | -2.5% | ||
| Q2 25 | -22517.7% | 7.8% | ||
| Q1 25 | -173943.0% | 17.9% | ||
| Q4 24 | — | — | ||
| Q3 24 | -21467.6% | -11.7% | ||
| Q2 24 | -16365.9% | -28.0% | ||
| Q1 24 | -26140.0% | -6.0% |
每股收益（稀释后）CDIOICCC
| Q4 25 | — | — | ||
| Q3 25 | $-0.98 | $-0.02 | ||
| Q2 25 | $-0.97 | $0.06 | ||
| Q1 25 | $-0.97 | $0.16 | ||
| Q4 24 | — | $0.09 | ||
| Q3 24 | $-1.73 | $-0.09 | ||
| Q2 24 | $-1.71 | $-0.20 | ||
| Q1 24 | $-5.93 | $-0.06 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | $3.9M |
| 总债务越低越好 | — | $9.5M |
| 股东权益账面价值 | $7.0M | $29.8M |
| 总资产 | $7.8M | $45.7M |
| 负债/权益比越低杠杆越低 | — | 0.32× |
8季度趋势，按日历期对齐
现金及短期投资CDIOICCC
| Q4 25 | — | — | ||
| Q3 25 | — | $3.9M | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $3.8M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | $1.3M | ||
| Q1 24 | — | $960.3K |
总债务CDIOICCC
| Q4 25 | — | — | ||
| Q3 25 | — | $9.5M | ||
| Q2 25 | — | — | ||
| Q1 25 | — | $8.7M | ||
| Q4 24 | — | $9.0M | ||
| Q3 24 | — | $9.4M | ||
| Q2 24 | — | $9.8M | ||
| Q1 24 | — | $10.2M |
股东权益CDIOICCC
| Q4 25 | $7.0M | — | ||
| Q3 25 | $8.2M | $29.8M | ||
| Q2 25 | $9.7M | $29.9M | ||
| Q1 25 | $11.4M | $29.0M | ||
| Q4 24 | $9.6M | $27.5M | ||
| Q3 24 | $3.7M | $26.4M | ||
| Q2 24 | $3.1M | $23.5M | ||
| Q1 24 | $3.0M | $24.6M |
总资产CDIOICCC
| Q4 25 | $7.8M | — | ||
| Q3 25 | $8.8M | $45.7M | ||
| Q2 25 | $10.4M | $46.7M | ||
| Q1 25 | $12.3M | $45.6M | ||
| Q4 24 | $10.6M | $45.1M | ||
| Q3 24 | $4.5M | $44.4M | ||
| Q2 24 | $4.0M | $41.9M | ||
| Q1 24 | $4.3M | $43.1M |
负债/权益比CDIOICCC
| Q4 25 | — | — | ||
| Q3 25 | — | 0.32× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | 0.30× | ||
| Q4 24 | — | 0.33× | ||
| Q3 24 | — | 0.36× | ||
| Q2 24 | — | 0.42× | ||
| Q1 24 | — | 0.41× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-5.7M | $-1.2M |
| 自由现金流经营现金流 - 资本支出 | $-5.9M | $-1.8M |
| 自由现金流率自由现金流/营收 | -166361.5% | -32.3% |
| 资本支出强度资本支出/营收 | 5269.1% | 10.8% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-10.5M | $715.4K |
8季度趋势，按日历期对齐
经营现金流CDIOICCC
| Q4 25 | $-5.7M | — | ||
| Q3 25 | $-1.4M | $-1.2M | ||
| Q2 25 | $-1.6M | $1.6M | ||
| Q1 25 | $-1.4M | $1.6M | ||
| Q4 24 | $-5.0M | $-3.1K | ||
| Q3 24 | $-1.2M | $-639.3K | ||
| Q2 24 | $-1.2M | $581.8K | ||
| Q1 24 | $-1.2M | $418.5K |
自由现金流CDIOICCC
| Q4 25 | $-5.9M | — | ||
| Q3 25 | $-1.6M | $-1.8M | ||
| Q2 25 | $-1.6M | $1.4M | ||
| Q1 25 | $-1.4M | $1.2M | ||
| Q4 24 | $-5.2M | $-199.3K | ||
| Q3 24 | $-1.2M | $-727.7K | ||
| Q2 24 | $-1.4M | $471.0K | ||
| Q1 24 | $-1.3M | $348.1K |
自由现金流率CDIOICCC
| Q4 25 | -166361.5% | — | ||
| Q3 25 | -54509.7% | -32.3% | ||
| Q2 25 | -21273.1% | 22.4% | ||
| Q1 25 | -149562.6% | 15.4% | ||
| Q4 24 | -115422.6% | -2.6% | ||
| Q3 24 | -17942.3% | -12.1% | ||
| Q2 24 | -17513.3% | 8.6% | ||
| Q1 24 | -7866.9% | 4.8% |
资本支出强度CDIOICCC
| Q4 25 | 5269.1% | — | ||
| Q3 25 | 5703.5% | 10.8% | ||
| Q2 25 | 250.1% | 2.4% | ||
| Q1 25 | 615.6% | 4.1% | ||
| Q4 24 | 4759.9% | 2.5% | ||
| Q3 24 | 353.3% | 1.5% | ||
| Q2 24 | 2133.4% | 2.0% | ||
| Q1 24 | 125.5% | 1.0% |
现金转化率CDIOICCC
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | 3.19× | ||
| Q1 25 | — | 1.09× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
